Form 4: Columbia Financial, Inc. Executive John Klimowich Reports Changes in Beneficial Ownership
SEC Form 4
EVP & Chief Risk Officer John Klimowich reports acquisition of phantom stock and adjustments to stock options and awards.
Summary
- John Klimowich, EVP & Chief Risk Officer of Columbia Financial, Inc., filed a Form 4 detailing changes in beneficial ownership.
- The report includes the acquisition of phantom stock through the Columbia Bank Stock Based Deferral Plan at a price of $16.38 per share, resulting in 5,878.1347 shares held indirectly.
- Klimowich directly owns 53,205 shares of common stock.
- He also indirectly owns shares through a 401(k) (17,130 shares), ESOP (6,451 shares), SERP (6,602 shares), SIM (4,214 shares), Stock Award (7,693 shares), Stock Award II (16,537 shares), and Stock Award III (13,165 shares).
- The report also details stock options to purchase 188,235 shares at $15.60 (exercisable from July 23, 2020), 12,030 shares at $15.94 (exercisable from May 1, 2024), and 8,850 shares at $16.49 (exercisable from March 6, 2025).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and neither positive nor negative sentiment is warranted.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in the financial services industry.
Comparison to Industry Standards
- Executive compensation packages including stock options and awards are standard practice in the banking industry to align management interests with shareholder value.
- Comparable companies like OceanFirst Financial Corp. and Provident Financial Services, Inc. also utilize equity-based compensation as part of their executive remuneration strategy.
- The vesting schedules and performance-based criteria for the stock awards are typical features designed to incentivize long-term performance.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
- It assures stakeholders that executives' interests are aligned with the company's performance through equity-based incentives.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Commencement of vesting for stock options (right to buy) at $15.6 |
| 05/01/2024 | Commencement of vesting for stock options (right to buy) at $15.94 and Stock Awards II |
| 03/06/2025 | Commencement of vesting for stock options (right to buy) at $16.49 and Stock Awards III |
| 03/22/2024 | Date of transaction for phantom stock purchase |
| 03/26/2024 | Date of signature for the report |
| 05/01/2033 | Expiration date for stock options (right to buy) at $15.94 |
| 03/06/2034 | Expiration date for stock options (right to buy) at $16.49 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.